- Athens 2019
- Paris 2019
- ESCRS Player
- On Demand
- ESCRS iLearn
- ESCRS YO's
Session Title: Intracorneal inlays for correction of presbyopia
Session Date/Time: Tuesday 08/10/2013 | 08:00-10:30
Paper Time: 09:36
Venue: Main Lecture Hall (Ground Floor)
First Author: : A.Almeida Jr BRAZIL
Co Author(s): : M. Dantas
To evaluate the safety, visual outcomes and patient satisfaction after monocular corneal inlay implantation for emetropic presbyopic patients.
HVISĆO Hospital da Visćo de Pernambuco, Recife, Brazil.
The Microlens (Presbia Flexivue Microlens, Presbia Coöperatief U.A., Netherlands) was implanted in the nondominant eye of 10 emetropic presbyopic patients after creation of a 300 micron deep corneal pocket using a femtosecond laser. . Distance and near vision was assessed preoperatively and postoperatively on day 1, and at Months 1 and 3. Patients were asked questions regarding their postoperative outcomes., and underwent biomicroscopy, central keratometry, and endotelial cell count measurements.
Uncorrected near visual acuity (UNVA) improved from a preoperative mean of Jaeger (J) 5 to J1 in all (100%) patients. Binocular uncorrected distance visual acuity (UDVA) did not change after the surgery, but decreased from 20/20 to 20/40 in 20% of operated eyes, to 20/30 in 50% of operated eyes, and to 20/25 in 30% in the operated eyes. 90% of patients reported excellent or good UDVA, and 100% of patients reported excellent or good UNVA. There were no adverse events reported through 3 months postoperative.
In this small cohort study, Presbia Flexivue Microlens implantation was a safe, and provided patients with excellent postoperative UNVA. The implantation of this lens in the cornea is an effective surgical option to treat emetropic patients with presbyopia.
Please wait while information is loading.